Status:
UNKNOWN
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
Lead Sponsor:
ProofPilot
Collaborating Sponsors:
Radish Health
Sanesco
Conditions:
COVID19
COVID-19
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Radish Health and ProofPilot in coordination with Sanesco are running this study to help establish whether the Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma Authorized...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Reside and Currently in New York City
- Does not have a blood clotting disease
- Is not abnormally queasy about taking a blood sample
- Not on any blood thinning medications
- Able to consent
- Willingness to take a blood sample
- Confirmed of highly likely past infection with COVID-19 over 14 days ago and fully recovered
Exclusion
Key Trial Info
Start Date :
April 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 29 2020
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04393961
Start Date
April 5 2020
End Date
August 29 2020
Last Update
May 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ProofPilot Online App (https://p.proofpilot.com)
New York, New York, United States, 10003